Positron Emission Tomography System Cleared by FDA

Food and Drug Administration (FDA). The system enables doctors to monitor the efficacy and side effects of chemotherapy drugs and reduces scanning time from 40 to 20 minutes.

The new PET system, called Ecat Accel, utilizes lutetium oxyortho-silicate (LSO), a new crystal material with significant high-energy imaging characteristics to improve patient throughput while maintaining superb image quality for oncology and cardiology indications. The system was developed by CTI, Inc. (Knoxville, TN, USA) and is distributed worldwide by Siemens Nuclear Medicine Group (Erlangen, Germany).

"The Ecat Accel image will tell physicians exactly what impact chemotherapy drugs are having on specific metabolic activities,” said Ron Nutt, senior vice president, technology development, CTI. "Further, the reduced scanning time will be more comfortable for patients undergoing the procedure.”



Related Links:
Siemens